Project Details
Description
A Phase III, multi-center, placebo-controlled, randomized, double-blind study to evaluate the safety and efficacy of PROCHYMAL (ex vivo cultured adult human
| Status | Finished |
|---|---|
| Effective start/end date | 6/8/07 → 12/31/10 |
Funding
- DUKE UNIVERSITY
- Osiris Therapeutics, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.